Propac To Recommend Reclassification Of Five Leukemia/Lymphoma Diagnosis Related Groups
In Brief: AACR To Have Fur Symposia, Including One With ASCO; McConnell Names TRTP Director
LAK/IL-2 Therapy Could Halt Kidney Cancer Deaths: DeVita
Cancer Education Applications Suspended Pending Restructuring
Caution Advised for Hormone Replacement Therapy
NLMs Grateful MED Aids Data Searches
FDA Committee Approves NDA for Mitxantrone
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- No need for a speculum? A new era of HPV screening
- Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- At AACR, Letai announces prevention and screening project for southern Appalachia, describes a future without paylines
There’s “clear evidence that funding is moving and the system is working.” - Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Forty years after Chernobyl: Little evidence to show that radiation released from the accident increased cancers globally









